Q/C TECHNOLOGIES, INC. — Director's Dealing 2021

Apr 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MyMD Pharmaceuticals, Inc. (MYMD)
CIK: 0001321834
Period of Report: 2021-04-16

Reporting Person: Silverman Joshua (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-16	Common Stock	M	109500	—	Acquired	112101	Direct
2021-04-16	Common Stock	F	38325	$4.94	Disposed	71175	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-16	Restricted Stock Units	$	M	109500	Disposed		Common Stock (109500)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the "Company").

F2: Represents 38,325 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 109,500 shares of RSUs on April 16, 2021.

F3: On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control.